NCT05121259 Feasibility and Acceptability of an Web-based Physical Activity Program, for Those Diagnosed With Lung Cancer. Status COMPLETED Phase NA
NCT05120050 Clinical Evaluation of ASP Health's Automated ROSE System for Bronchoscopic Applications Status UNKNOWN Phase N/A
NCT05118854 A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05117372 ANALYSIS OF INFLAMMATORY REACTIONS OBSERVED IN BRONCHOALVEOLAR LAVAGES (BALS) Status UNKNOWN Phase NA
NCT05110131 Evaluation of the Synergistic Impact of Needle and Forceps Biopsy With Electromagnetic Navigation Bronchoscopy Status ACTIVE_NOT_RECRUITING Phase NA
NCT05099237 Enhanced Monitoring for Better Recovery and Cancer Experience in Greater Manchester Status UNKNOWN Phase NA
NCT05094843 The Cardiac Stress and Electrocardiographic Changes Caused by Lung Cancer Surgery Status RECRUITING Phase N/A
NCT05092412 Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05092009 Lung Cancer Organoids and Patient Derived Tumor Xenografts Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05078918 Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors Status UNKNOWN Phase NA
NCT05073991 Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR. Status UNKNOWN Phase N/A
NCT05072561 Feasibility of Radioisotope-guided Excision of Mediastinal Lymph Nodes in Patients With Non-small Cells Lung Carcinoma Status UNKNOWN Phase NA
NCT05071014 A Study of Pembrolizumab and Cryoablation in People With Mesothelioma Status COMPLETED Phase PHASE1
NCT05069792 Utrecht COhort for Lung Cancer Outcome Reporting and Trial Inclusion (U-COLOR) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05068973 Evaluation of the NOVATECH ® LUCIOLA TM EB Fiducial Marker During Radiotherapy Sessions in Lung Cancer Patients Status UNKNOWN Phase NA
NCT05068232 Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES) Status RECRUITING Phase PHASE2